Definitive Healthcare Corp. (DH) stock
DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3066% below fair value
$1.34+0.03 (+2.29%)
Close on Nov 18, 2026Market cap $143.04MP/E –Yield –
Definitive Healthcare free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Definitive Healthcare's free cash flow for the twelve months ending Jun 30, 2026 was $28.56M. For fiscal 2025 it was $37.06M, down 19.2% from the year before. The highest annual figure on record is $45.85M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.06M | -19.2% |
| FY2024 | Dec 31, 2024 | $45.85M | +20.0% |
| FY2023 | Dec 31, 2023 | $38.21M | +40.2% |
| FY2022 | Dec 31, 2022 | $27.25M | +47.5% |
| FY2021 | Dec 31, 2021 | $18.48M | -15.3% |
| FY2020 | Dec 31, 2020 | $21.82M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.51M | +21.4% |
| Q1 FY2026 | Mar 31, 2026 | $8.36M | -54.5% |
| Q4 FY2025 | Dec 31, 2025 | -$1.72M | – |
| Q3 FY2025 | Sep 30, 2025 | $13.41M | -55.2% |
| Q2 FY2025 | Jun 30, 2025 | $7.01M | +70.4% |
| Q1 FY2025 | Mar 31, 2025 | $18.36M | +100.0% |
| Q4 FY2024 | Dec 31, 2024 | -$2.77M | -124.5% |
| Q1 FY2024 | Jun 30, 2024 | $29.95M | +119.9% |
| Q4 FY2023 | Dec 31, 2023 | $4.12M | – |
| Q3 FY2023 | Sep 30, 2023 | $9.18M | +4.3% |
| Q2 FY2023 | Jun 30, 2023 | $11.30M | -23.1% |
| Q1 FY2023 | Mar 31, 2023 | $13.62M | +6.1% |
| Q4 FY2022 | Dec 31, 2022 | -$9.09M | -388.6% |
| Q3 FY2022 | Sep 30, 2022 | $8.81M | – |
| Q2 FY2022 | Jun 30, 2022 | $14.70M | +109.0% |
| Q1 FY2022 | Mar 31, 2022 | $12.84M | +32.6% |
| Q4 FY2021 | Dec 31, 2021 | $3.15M | -62.2% |
| Q3 FY2021 | Sep 30, 2021 | -$1.39M | – |
| Q2 FY2021 | Jun 30, 2021 | $7.03M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.69M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.34M | – |
See a number that looks wrong?